Savara Inc.

SVRA

$5.35

-0.47%-$0.02

High—

Low—

52W High-23.6%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

AI analysis

Savara Inc. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$5.38

5-period simple moving average

SMA10

$5.36

10-period simple moving average

SMA20

$5.35

20-period simple moving average

SMA50

$5.33

50-period simple moving average

EMA5

$5.37

5-period exponential moving average

EMA10

$5.36

10-period exponential moving average

EMA20

$5.35

20-period exponential moving average

DEMA20

$5.37

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$5.35

Volume weighted average price

MACD

0.013

Signal 0.011

RSI(14)

54.3

Relative strength oscillator

OBV

-26.05K

On-balance volume

StochRSI

54.3 / 54.3

Fast oscillator pair

BBands Low

$5.32

Lower band

BBands Mid

$5.35

Middle band

BBands High

$5.39

Upper band

Market Cap

1.10B

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

-4.76

Enterprise value multiple

ROE

-105.5%

Return on equity

ROA

-50.1%

Return on assets

Operating Margin

0.0%

Operating efficiency

Net Margin

0.0%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

0.26

Market sensitivity

52W High

$7.00

52-week peak

52W Low

$3.34

52-week trough

Supply Chain of SVRA

Upstream / Downstream / Proxies

Upstream

GEMA Biotech S.A.Fujifilm Diosynth Biotechnologies (subsidiary of Fujifilm Holdings Corp)TSE:4901PARI Pharma GmbHAMEGA Biotech / Megalabs (parent of GEMA Biotech)PARI component suppliers (various precision engineering firms)

Downstream

PANTHERx RareRTW Investments, LP / RTW Biotech Opportunities LtdLSE:RTWU.S. hospitals, pulmonology clinics, and aPAP patientsEU/UK patients, hospitals, and healthcare systems

Proxies

Fujifilm Holdings CorporationTSE:4901RTW Biotech Opportunities LtdLSE:RTWCentene CorporationNYSE:CNC

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer